FBRX Antony A Riley buys $125K worth of shares
Nov 23, 2024, 5:32 AM
-10.92%
What does FBRX do
Forte Biosciences, a Dallas-based biopharmaceutical company, specializes in dermatology products and is advancing product candidate FB-102 for autoimmune diseases. The company went public on April 13, 2017, and holds a U.S. patent for skin treatment.
Antony A Riley bought 22,514 shares of FBRX on 21 November at $5.55 per share, worth a total of $125K. They now own 30,776 FBRX shares, or a 273% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.